Russian Federation has become the first nation to complete clinical trials of Covid-19 vaccine on humans, and the results have proven the medication's effectiveness, the media reported on Sunday. The second batch will discharge from the institute later on July 20.
Russian Federation had allowed clinical trials of two forms of a potential Covid-19 vaccine developed by the Gamaleya National Research Center for Epidemiology and Microbiology on June 18.
Several institutions across the globe are dedicating their time and resource in developing proper Covid-19 vaccines.
The report, citing Citing Alexander Lukashev, the director of the Institute of Medical Parasitology, Tropical, and Vector-Borne Diseases at Sechenov University, said the study has been conducted to check the COVID-19 vaccine's safety when given to humans and it has been successfully completed. Two experimental vaccines developed by Sinovac Biotech and a unit of China National Pharmaceutical Group (Sinopharm) are already approved for Phase III trials.
Stanford and Harvard university-educated Kirill Dmitriev, CEO of Russian Direct Investment Fund (RDIF), commented: "The Russian research base for vaccine development is one of the best globally, and we expect that the Russian vaccine will be one of the first in the world ready to be used", reported TrialSiteNews.
"The safety of the vaccine has been confirmed". Clinical trials for the drug are now in their final stage.
Vadim Tarasov, the director of the Institute for Translational Medicine and Biotechnology, told Sputnik that the university has completed the trial of the vaccine developed by the Gamaleya Institute, an epidemiology research centre in Moscow.
Earlier, on June 30, researchers said they had not observed any adverse side effects of the vaccine on volunteers. The first group, aged 18 to 60, will receive different doses of the vaccine, he said. "It corresponds to the safety of those vaccines that are now on the market", Alexander Lukashev, the director of the Institute of Medical Parasitology, Tropical, and Vector-Borne Diseases at Sechenov University, was quoted as saying. With more than 10 million confirmed cases and more than 5,60,000 deaths, this dreaded pandemic has literally changed the entire course of humanity. Now, the manufacturer is moving forward to develop further vaccines for containing coronavirus.